Figure 6 | Scientific Reports

Figure 6

From: A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease

Figure 6

Comparison of predominant phyla in the microbiota of mice cecums. (A) Change of individual mouse cecum microbiota at the phylum level after MPTP and/or probiotic application. (B) Predominant phylum in the cecum microbiome of mice and pair wise comparison of each group. Statistical p-values were assessed using a Monte-Carlo test with 10,000 replicates. MPTP mice were received (i.p.) 30 mg/kg MPTP-HCl daily for 5 consecutive days (MPTP and MPTP + P). Probiotic mice were administered 1 dose (108 CFU/mouse/day) daily of L. rhamnosus E9 for fifteen days and sacrificed after the last dose (P and MPTP + P). *p ≤ 0.05, (n:5/group).

Back to article page